Evidence-Based Complementary and Alternative Medicine / 2018 / Article / Tab 1 / Review Article
A Meta-Analysis of the Clinical Efficacy of TCM Decoctions Made from Formulas in the Liuwei Dihuang Wan Categorized Formulas in Treating Diabetic Nephropathy Proteinuria Table 1 Characteristics and methodological quality of included studies.
Reference (year) Participants (T/C) stages of Mogensen Average age (years) Intervention (dosage) Control (dosage) Treatment duration (days) Zhou (2009) [24 ] 90 (48/42) Phase III T 55.3; C 53.8 Jisheng Shenqi Wan pluse Captopril (25-75mg/d) Captopril (25-75mg/d) 42 Zhang (2012) [25 ] 46 (23/23) Phase II-IV T 36.5; C 35.3 Jisheng Shenqi Wan pluse Benazepril Hydrochloride (10mg, qd) Benazepril Hydrochloride (10mg, qd) 40 Yu (2008) [26 ] 60 (30/30) Phase III T 53±17; C 54±16 Liuwei Dihuang Wan pluse Valsartan (80mg/d) Valsartan (80mg/d) 84 Xia (2008) [27 ] 64 (32/32) Phase IV T 56.70±4.23; C 55.34±3.33 Jingui Shenqi Wan pluse Valsartan (80mg/d) Valsartan (80mg/d) 30 Xiong et al. (2003) [28 ] 78 (40/38) Phase IV T 46.35±4.17; C 43.58±4.16 Jisheng Shenqi Wan pluse Captopril (25-75mg/d) Captopril (25-75mg/d) 42 Wu (2016) [29 ] 37 (18/19) Phase III —— Jingui Shenqi Wan Routine treatment 30 Wen (2011) [30 ] 40 (20/20) Phase IV T 52.5±11.5; C 50.1±10.7 Liuwei Dihuang Wan pluse Astragalus membranaceus pluse Captopril (25mg/d) Captopril (25mg/d) 28 Tan (2014) [31 ] 43 (22/21) Phase IV T 59.72±3.17; C 61.32±2.27 Liuwei Dihuang Wan pluse Benazepril Hydrochloride (10mg, qd) Benazepril Hydrochloride (10mg, qd) 56 Liu et al. (2014) [32 ] 158 (79/79) Phase IV T 57.5±20.1; C 58.6±19.3 Liuwei Dihuang Wan Routine treatment 60 Li (2004) [33 ] 40 (20/20) Phase III T 51.3; C 52.3 Liuwei Dihuang Wan pluse Enalapril (10mg/d) Enalapril (10mg/d) 84 Lei (2011) [34 ] 84 (43/41) Phase III T 55.44±5.98; C 55.95±6.99 Liuwei Dihuang Wan Telmisartan (80mg/d) 84 Jin (2014) [35 ] 50 (25/25) Phase III T 40±13.5; C 38±12.3 Liuwei Dihuang Wan pluse Valsartan (80mg/d) Valsartan (80mg/d) 90 Cui et al. (2011) [36 ] 66 (33/33) Phase III 52.3 Liuwei Dihuang Wan Routine treatment 56 Zhang (2004) [37 ] 62 (31/31) Phase III T 59.8; C 58.4 Zhibai Dihuang Wan Routine treatment 90